Patterns and Correlates of Serum Magnesium Levels in Subsets of Type 2 Diabetes Mellitus Patients in Nigeria

Background: Magnesium (Mg) is the 4th most common mineral and the 2nd most abundant intracellular cation in the body. It plays major roles in various physiological activities and has been implicated in many disease states. Aim: The aim of this study was to study the patterns and correlates of serum Mg in cohorts of type 2 diabetic patients in Nigeria. Subjects and Methods: One hundred and twenty-five patients comprising 63 with type 2 diabetes mellitus (T2DM) alone and 62 with diabetes and hypertension (HT) were compared with fifty controls matched for sex and age. Basic data, HbA1c, and fasting blood glucose (FBG) were obtained while serum Mg was measured by colorimeter. Relationship between serum Mg and glucose control was considered while serum Mg < 1.6 mg/dl was considered as hypomagnesemia. Results: The mean serum Mg of all patients was 2.06 ± 0.49 mg/dl, not statistically different from controls at 2.22 ± 0.48 mg/dl. About ¼ (23.2%) of the patients had hypomagnesemia which was significantly more than 12% of controls. Although the patients with diabetes and HT were older and more of females than those with DM alone, the mean serum Mg was comparable (2.03 ± 0.49 vs. 2.09 + 0.50 mg/dl). Twenty-seven percent (27%) of patients who had DM alone was more than 19.3% with HT and diabetes combined. Whereas the FBG was comparable in patients with hypomagnesemia and normal serum Mg, HbA1c was significantly higher in the hypomagnesemia group (8.39 ± 0.98 vs. 6.75 ± 1.22%, P = 0.021). Conclusion: Hypomagnesemia is common in T2DM outpatients occurring approximately one in four patients. It is associated with poor long-term control.

[1]  Sudha Prasanna,et al.  Hypomagnesemia in Type-2 Diabetes Mellitus , 2018 .

[2]  M. Rodríguez-Moran,et al.  Obesity and hypomagnesemia. , 2016, European journal of internal medicine.

[3]  Yiqing Song,et al.  Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials. , 2016, Hypertension.

[4]  Sangeeta Mutnuri,et al.  Suppression of Parathyroid Hormone in a Patient with Severe Magnesium Depletion , 2016, Case reports in nephrology.

[5]  N. Sarrafzadegan,et al.  Magnesium status and the metabolic syndrome: A systematic review and meta-analysis. , 2016, Nutrition.

[6]  Srinivasan Ar,et al.  SERUM magnesium levels as an indicator of status of Diabetes Mellitus type 2. , 2015, Diabetes & metabolic syndrome.

[7]  S. Pham,et al.  Hypomagnesemia: a clinical perspective , 2014, International journal of nephrology and renovascular disease.

[8]  J. Meigs,et al.  Higher Magnesium Intake Reduces Risk of Impaired Glucose and Insulin Metabolism and Progression From Prediabetes to Diabetes in Middle-Aged Americans , 2014, Diabetes Care.

[9]  N. Khan,et al.  Serum magnesium in hospital admitted diabetic patients. , 2014, Mymensingh medical journal : MMJ.

[10]  S. Volpe Magnesium in disease prevention and overall health. , 2013, Advances in nutrition.

[11]  E. Adewoye,et al.  Effect of magnesium on gastrointestinal transit time in normal and diabetic rats: possible mechanism of action. , 2012, African journal of medicine and medical sciences.

[12]  K. He,et al.  Magnesium Intake and Risk of Type 2 Diabetes , 2011, Diabetes Care.

[13]  E. Adewoye,et al.  Effect of Magnesium pre-treatment on alloxan induced hyperglycemia in rats. , 2011, African health sciences.

[14]  F. Nielsen,et al.  Magnesium, inflammation, and obesity in chronic disease. , 2010, Nutrition reviews.

[15]  M. Arnaud Update on the assessment of magnesium status. , 2008, The British journal of nutrition.

[16]  Jeffrey M. Miller,et al.  Hypomagnesemia in patients with type 2 diabetes. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[17]  M. Barbagallo,et al.  Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. , 2007, Archives of biochemistry and biophysics.

[18]  D. Kochar,et al.  Serum magnesium: an early predictor of course and complications of diabetes mellitus. , 2007, Journal of the Indian Medical Association.

[19]  M. Zimmermann,et al.  Low plasma magnesium in type 2 diabetes. , 2003, Swiss medical weekly.

[20]  M. Barbagallo,et al.  Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. , 1997, American journal of hypertension.

[21]  R. Elin Magnesium: the fifth but forgotten electrolyte. , 1994, American journal of clinical pathology.